Skip to main content
. 2021 Oct 11;4(10):e2128271. doi: 10.1001/jamanetworkopen.2021.28271

Table 1. Univariate and Multivariate Analysis for First Clinical Demyelinating Event.

Variable Patient population, No. Univariate analysis Multivariate analysis
HR (95% CI) P value HR (95% CI) P value
Age <37 y 354 3.52 (1.80-6.88) <.001 4.04 (2.00-8.15) <.001
Women 354 1.27 (0.68-2.36) .45 NA NA
Positive family MS history 354 0.86 (0.36-1.81) .73 NA NA
MRI motive (headache) 354 0.64 (0.32-1.28) .21 NA NA
Positive CSF IgG index >0.7l or presence of >2 unique OCBs 354 1.26 (0.51-3.09) .61 NA NA
Not >3 periventricular lesions 349 1.59 (0.57-4.45) .38 NA NA
Infratentorial lesion presence 349 1.76 (0.98-3.15) .06 NA NA
Juxtacortical lesion presence 349 NAa NA NA NA
Spinal cord lesion presence 173 3.82 (1.50-9.70) .005 5.11 (1.99-13.13) .001
Gadolinium-enhancing lesions on index MRI 354 2.11 (1.16-3.83) .01 2.09 (1.33-3.87) .02
Disease modifying treatment) 61 7.49 (4.24-13.24) <.001 0.85 (0.26-2.81) .79

Abbreviations: CSF, cerebrospinal fluid; HR, hazard ratio; MRI, magnetic resonance imaging; MS, multiple sclerosis; NA, not applicable; OCB, oligoclonal band.

a

This result was not estimable given that no clinical conversion was observed for patients with juxtacortical lesions.